Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 9 , Pages 884-893 , September 2009

Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders

,Accepted 11 June 2009.

References 

  1. Physicians' Desk Reference . 61st ed.. Montvale, NJ: Thomson PDR; 2007;
  2. Robertson MM , Eapen V . Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome . Clin Neuropharmacol . 1992;15:408–425
  3. Khalifa N , von Knorring AL . Psychopathology in a Swedish population of school children with tic disorders . J Am Acad Child Adolesc Psychiatry . 2006;45:1346–1353
  4. Spencer T , Biederman J , Harding M , et al.   Disentangling the overlap between Tourette's disorder and ADHD . J Child Psychol Psychiatry . 1998;39:1037–1044
  5. Sukhodolsky DG , Scahill L , Zhang H , et al.   Disruptive behavior in children with Tourette's syndrome: association with ADHD comorbidity, tic severity, and functional impairment . J Am Acad Child Adolesc Psychiatry . 2003;42:98–105
  6. Dulcan M . Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry . J Am Acad Child Adolesc Psychiatry . 1997;36(10 Suppl):85S–121S
  7. Van der Oord S , Prins PJ , Oosterlaan J , Emmelkamp PM . Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis . Clin Psychol Rev . 2008;28:783–800
  8. The MTA Cooperative Group  . A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD . Arch Gen Psychiatry . 1999;56:1073–1086
  9. Faraone SV , Biederman J , Spencer TJ , Aleardi M . Comparing the efficacy of medications for ADHD using meta-analysis . MedGenMed . 2006;8:4
  10. Jadad AR , Boyle M , Cunningham C , Kim M , Schachar R . Treatment of attention-deficit/hyperactivity disorder . Evid Rep Technol Assess (Summ) . 1999;i–viii 1–341.
  11. Spencer T , Biederman J , Wilens T , Harding M , O'Donnell D , Griffin S . Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle . J Am Acad Child Adolesc Psychiatry . 1996;35:409–432
  12. Golden GS . The effect of central nervous system stimulants on Tourette syndrome . Ann Neurol . 1977;2:69–70
  13. Denckla MB , Bemporad JR , MacKay MC . Tics following methylphenidate administration. A report of 20 cases . JAMA . 1976;235:1349–1351
  14. Lowe TL , Cohen DJ , Detlor J , Kremenitzer MW , Shaywitz BA . Stimulant medications precipitate Tourette's syndrome . JAMA . 1982;247:1168–1169
  15. Madras BK , Miller GM , Fischman AJ . The dopamine transporter and attention-deficit/hyperactivity disorder . Biol Psychiatry . 2005;57:1397–1409
  16. Albin RL . Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function . Adv Neurol . 2006;99:99–106
  17. Mink JW . Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis . Pediatr Neurol . 2001;25:190–198
  18. Leckman JF . Tourette's syndrome . Lancet . 2002;360:1577–1586
  19. Shapiro AK , Shapiro E . Controlled study of pimozide vs. placebo in Tourette's syndrome . J Am Acad Child Psychiatry . 1984;23:161–173
  20. Nolan EE , Gadow KD , Sverd J . Observations and ratings of tics in school settings . J Abnorm Child Psychol . 1994;22:579–593
  21. Leckman JF , Riddle MA , Hardin MT , et al.   The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity . J Am Acad Child Adolesc Psychiatry . 1989;28:566–573
  22. Walkup JT , Rosenberg LA , Brown J , Singer HS . The validity of instruments measuring tic severity in Tourette's syndrome . J Am Acad Child Adolesc Psychiatry . 1992;31:472–477
  23. Achenbach TM , Edelbrock CS . Manual for the Child Behavior Checklist . Burlington, VT: University of Vermont Department of Psychiatry; 1991;
  24. Werry JS , Sprague RL , Cohen MN . Conners' Teacher Rating Scale for use in drug studies with children–an empirical study . J Abnorm Child Psychol . 1975;3:217–229
  25. DuPaul G . Parent and teacher rating of ADHD symptoms: psychometric properties in a community-based sample . J Clin Child Psychol . 1991;20:245–253
  26. Pelham WE , Milich R , Murphy DA , Murphy HA . Normative data on the Iowa Conners teacher rating scale . J Clin Child Psychol . 1989;1989:259–262
  27. Goyette CH , Conners CK , Ulrich RF . Normative data on revised Conners Parent and Teacher Rating Scales . J Abnorm Child Psychol . 1978;6:221–236
  28. Elbourne DR , Altman DG , Higgins JP , Curtin F , Worthington HV , Vail A . Meta-analyses involving cross-over trials: methodological issues . Int J Epidemiol . 2002;31:140–149
  29. Curtin F , Altman DG , Elbourne D . Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes . Stat Med . 2002;21:2131–2144
  30. Bloch MH , Landeros-Weisenberger A , Dombrowski P , et al.   Systematic review: pharmacological and behavioral treatment for trichotillomania . Biol Psychiatry . 2007;62:839–846
  31. Review Manager (RevMan) [computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2003.
  32. Egger M , Davey Smith G , Schneider M , Minder C . Bias in meta-analysis detected by a simple, graphical test . BMJ . 1997;315:629–634
  33. Castellanos FX , Giedd JN , Elia J , et al.   Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose . J Am Acad Child Adolesc Psychiatry . 1997;36:589–596
  34. Gadow KD , Nolan EE , Sverd J . Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings . J Am Acad Child Adolesc Psychiatry . 1992;31:462–471
  35. Gadow KD , Sverd J , Nolan EE , Sprafkin J , Schneider J . Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder . J Am Acad Child Adolesc Psychiatry . 2007;46:840–848
  36. Scahill L , Chappell PB , Kim YS , et al.   A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder . Am J Psychiatry . 2001;158:1067–1074
  37. Allen AJ , Kurlan RM , Gilbert DL , et al.   Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders . Neurology . 2005;65:1941–1949
  38. Tourette's Syndrome Study Group  . Treatment of ADHD in children with tics: a randomized controlled trial . Neurology . 2002;58:527–536
  39. Singer HS , Brown J , Quaskey S , Rosenberg LA , Mellits ED , Denckla MB . The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine . Pediatrics . 1995;95:74–81
  40. Spencer T , Biederman J , Coffey B , et al.   A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder . Arch Gen Psychiatry . 2002;59:649–656
  41. Feigin A , Kurlan R , McDermott MP , et al.   A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder . Neurology . 1996;46:965–968
  42. Spencer TJ , Sallee FR , Gilbert DL , et al.   Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome . J Atten Disord . 2008;11:470–481
  43. Gadow KD , Sverd J , Sprafkin J , Nolan EE , Ezor SN . Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder . Arch Gen Psychiatry . 1995;52:444–455
  44. Niederhofer H , Staffen W , Mair A . A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder . J Psychopharmacol . 2003;17:113–119
  45. Bailey J . An exceptional case of plagiarism! . J Psychopharmacol . 2004;18:291–292
  46. Swanson J , Arnold LE , Kraemer H , et al.   Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary . J Atten Disord . 2008;12:4–14
  47. Leckman JF , Ort S , Caruso KA , Anderson GM , Riddle MA , Cohen DJ . Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects . Arch Gen Psychiatry . 1986;43:1168–1176
  48. Biederman J , Baldessarini RJ , Wright V , Knee D , Harmatz JS , Goldblatt A . A double-blind placebo controlled study of desipramine in the treatment ADD: II. Serum drug levels and cardiovascular findings . J Am Acad Child Adolesc Psychiatry . 1989;28:903–911
  49. Scahill L , Erenberg G , Berlin CM , et al.   Contemporary assessment and pharmacotherapy of Tourette syndrome . NeuroRx . 2006;3:192–206
  50. Wilens TE , Spencer TJ , Swanson JM , Connor DF , Cantwell D . Combining methylphenidate and clonidine: a clinically sound medication option . J Am Acad Child Adolesc Psychiatry . 1999;38:614–619 discussion 619–622.
  51. Daviss WB , Patel NC , Robb AS , et al.   Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis . JAm Acad Child Adolesc Psychiatry . 2008;47:189–198
  52. Schachter HM , Pham B , King J , Langford S , Moher D . How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis . CMAJ . 2001;165:1475–1488
  53. Connor DF , Fletcher KE , Swanson JM . A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder . J Am Acad Child Adolesc Psychiatry . 1999;38:1551–1559
  54. Cheng JY , Chen RY , Ko JS , Ng EM . Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis . Psychopharmacology (Berl) . 2007;194:197–209

 This article was reviewed under and accepted by Deputy Editor John T. Walkup, M.D.All of the authors are with the Yale Child Study Center, Yale University School of Medicine.The authors acknowledge the National Institute of Mental Health support of the Yale Child Study Center Research Training Program (M.H.B. and J.F.L.), K05MH076273 (J.F.L.), the National Institute of Health Loan Repayment Program (M.H.B.), the support of the Tourette's Syndrome Association (J.F.L.), the APIRE/Eli Lilly Psychiatric Research Fellowship (M.H.B.), and the APA/NIMH PMRTP Program (A.L.W.).This article is the subject of an editorial by Dr. Eric Taylor in this issue.

PII: S0890-8567(09)60144-1

doi: 10.1097/CHI.0b013e3181b26e9f

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 48, Issue 9 , Pages 884-893 , September 2009

Article Tools

* Image Usage & Resolution